Lignan 7-hydroxymatairesinol in the context of post-genomic pharmacology

Objective: to determine the molecular mechanisms of action of 7-hydroxymatairesinol (7(OH)MR), the main lignan of spruce extracts, characterized by oncoprotective and anti-inflammatory properties.Material and methods. The analysis of 7(OH)MR was carried out by chemoinformatic approach using the comb...

Full description

Saved in:
Bibliographic Details
Main Authors: А. N. Rubashkina, I. Yu. Torshin, O. A. Gromova, A. N. Galustyan
Format: Article
Language:Russian
Published: IRBIS LLC 2024-08-01
Series:Фармакоэкономика
Subjects:
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/1012
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849249621961867264
author А. N. Rubashkina
I. Yu. Torshin
O. A. Gromova
A. N. Galustyan
author_facet А. N. Rubashkina
I. Yu. Torshin
O. A. Gromova
A. N. Galustyan
author_sort А. N. Rubashkina
collection DOAJ
description Objective: to determine the molecular mechanisms of action of 7-hydroxymatairesinol (7(OH)MR), the main lignan of spruce extracts, characterized by oncoprotective and anti-inflammatory properties.Material and methods. The analysis of 7(OH)MR was carried out by chemoinformatic approach using the combinatorial theory of solvability and the topological theory of recognition. The postgenomic approach makes it possible to assess the effect of drugs on genome transcription (transcriptome) and on the proteome as a whole.Results. 7(OH)MP has anti-inflammatory (inhibition of 5-lipoxygenase, matrix metalloproteinase 2, mitogen-activated kinase p38-alpha, leukotriene В4 receptor, prostacyclin receptor), and oncoprotective (antioxidant effect due to inhibition of heme oxygenase-2, inhibition of cyclin-dependent kinases 3 and 4, epidermal growth factor, mTOR protein) pharmacological effects.Conclusion. By reducing the expression of proliferative genes and genes involved in chronic inflammation, the 7(OH)MP molecule inhibits the proliferation of tumor cells. Pharmacoinformatic modeling showed that the anti-inflammatory effects of 7(OH)MR may contribute to increased lifespan in animal models.
format Article
id doaj-art-41b0bbea73ce4f67a6371668408e6b53
institution Kabale University
issn 2070-4909
2070-4933
language Russian
publishDate 2024-08-01
publisher IRBIS LLC
record_format Article
series Фармакоэкономика
spelling doaj-art-41b0bbea73ce4f67a6371668408e6b532025-08-20T03:57:31ZrusIRBIS LLCФармакоэкономика2070-49092070-49332024-08-0117219119910.17749/2070-4909/farmakoekonomika.2024.240486Lignan 7-hydroxymatairesinol in the context of post-genomic pharmacologyА. N. Rubashkina0I. Yu. Torshin1O. A. Gromova2A. N. Galustyan3Ivanovo State Medical AcademyFederal Research Center “Computer Science and Control”, Russian Academy of SciencesFederal Research Center “Computer Science and Control”, Russian Academy of SciencesSaint Petersburg State Pediatric Medical UniversityObjective: to determine the molecular mechanisms of action of 7-hydroxymatairesinol (7(OH)MR), the main lignan of spruce extracts, characterized by oncoprotective and anti-inflammatory properties.Material and methods. The analysis of 7(OH)MR was carried out by chemoinformatic approach using the combinatorial theory of solvability and the topological theory of recognition. The postgenomic approach makes it possible to assess the effect of drugs on genome transcription (transcriptome) and on the proteome as a whole.Results. 7(OH)MP has anti-inflammatory (inhibition of 5-lipoxygenase, matrix metalloproteinase 2, mitogen-activated kinase p38-alpha, leukotriene В4 receptor, prostacyclin receptor), and oncoprotective (antioxidant effect due to inhibition of heme oxygenase-2, inhibition of cyclin-dependent kinases 3 and 4, epidermal growth factor, mTOR protein) pharmacological effects.Conclusion. By reducing the expression of proliferative genes and genes involved in chronic inflammation, the 7(OH)MP molecule inhibits the proliferation of tumor cells. Pharmacoinformatic modeling showed that the anti-inflammatory effects of 7(OH)MR may contribute to increased lifespan in animal models.https://www.pharmacoeconomics.ru/jour/article/view/1012mastopathylignanspathogenetic therapypharmacoinformaticshuman proteometranscriptomics
spellingShingle А. N. Rubashkina
I. Yu. Torshin
O. A. Gromova
A. N. Galustyan
Lignan 7-hydroxymatairesinol in the context of post-genomic pharmacology
Фармакоэкономика
mastopathy
lignans
pathogenetic therapy
pharmacoinformatics
human proteome
transcriptomics
title Lignan 7-hydroxymatairesinol in the context of post-genomic pharmacology
title_full Lignan 7-hydroxymatairesinol in the context of post-genomic pharmacology
title_fullStr Lignan 7-hydroxymatairesinol in the context of post-genomic pharmacology
title_full_unstemmed Lignan 7-hydroxymatairesinol in the context of post-genomic pharmacology
title_short Lignan 7-hydroxymatairesinol in the context of post-genomic pharmacology
title_sort lignan 7 hydroxymatairesinol in the context of post genomic pharmacology
topic mastopathy
lignans
pathogenetic therapy
pharmacoinformatics
human proteome
transcriptomics
url https://www.pharmacoeconomics.ru/jour/article/view/1012
work_keys_str_mv AT anrubashkina lignan7hydroxymatairesinolinthecontextofpostgenomicpharmacology
AT iyutorshin lignan7hydroxymatairesinolinthecontextofpostgenomicpharmacology
AT oagromova lignan7hydroxymatairesinolinthecontextofpostgenomicpharmacology
AT angalustyan lignan7hydroxymatairesinolinthecontextofpostgenomicpharmacology